Interaction between erythromycin and the benzodiazepines diazepam and flunitrazepam

Pharmacology and Toxicology

Volumn 78, Issue 2, 1996, Pages 117-122

  Luurila, Harri ^a   Olkkola, Klaus T ^a   Neuvonen, Pertti J ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; DIAPAM; DIAZEPAM; DRUG METABOLITE; ERYTHROMYCIN; FLUNITRAZEPAM; NORDAZEPAM; UNCLASSIFIED DRUG;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; DRUG METABOLISM; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; RANDOMIZED CONTROLLED TRIAL; VOLUNTEER;

EID: 0030049943     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0773.1996.tb00191.x     Document Type: Article

References (29)

1. Andersson, T.: Omeprazole drug interaction studies. Clin. Pharmacokin. 1991, 21, 195-212.
2. Andersson, T., J. O. Miners, M. L. Veronese & D. J. Birkett: Diazepam metabolism by human liver microsomes is mediated by both S-mephenytoin hydroxylase and CYP3A isoforms. Brit. J. Clin. Pharmacol. 1994, 38, 131-137.
3. Aranko, K., H. Luurila, J. T. Backman, P. J. Neuvonen & K. T. Olkkola: The effect of erythromycin on the pharmacokinetics and pharmacodynamics of zopiclone. Brit. J. Clin. Pharmacol. 1994, 38, 363-367.
4. Bertilsson, L., T. K. Henthorn, E. Sanz, G. Tybring, J. Säwe & T. Ville: Importance of genetic factors in the regulation of diazepam metabolism: Relationship to S-mephenytoin, but not debrisoquin, hydroxylation phenotype. Clin. Pharmacol. Therap. 1989, 45, 348-355.
5. Bond, A. & M. H. Lader: The use of visual analogue scales in rating subjective feelings, Brit. J. Med. Psychol. 1974, 47, 211-218.
6. Brockmöller, J. & I. Roots: Assessment of liver metabolic function. Clin. Pharmacokin. 1994, 27, 216-248.
7. Brosen, K., F., Skjelbo, B. B. Rasmussen, H. E. Poulsen & S. Loft: Fluvoxamine is a potent inhibitor of cytochrome P4501A2. Biochem. Pharmacol. 1993, 45, 1211-1214.
8. De Kroon, I. F. I., P. N. J. Langendijk & P. N. F. C. De Goede: Simultaneous determination of midazolam and its three hydroxy metabolites in human plasma by electron-capture gas chromatography without derivatization. J. Chromatogr. 1989, 491, 107-116.
9. Gibaldi, M. & D. Perrier: Pharmacokinetics, 2nd ed. Marcel Dekker, New York, 1982.
10. Gillum, J. G., D. S. Israel & R. E. Polk: Pharmacokinetic drug interactions with antimicrobial agents. Clin. Pharmacokin. 1993, 25, 450-482.
11. Hannington-Kiff, J. G.: Measurements of recovery from outpatient general anaesthesia with simple ocular test. Brit. Med. J. 1970, 3, 132-135.
12. Janssens, J., T. L. Peeters, G. Vantrappen, J. Tack, J. L. Urbain, M. De Roo, E. Muls & R. Bouillon: Improvement of gastric emptying in diabetic gastroparesis by erythromycin. New Engl. J. Med. 1990, 322, 1028-1031.
13. Klotz, U. & I. Reimann: Delayed clearance by diazepam due to cimetidine. New Engl. J. Med. 1980, 302, 1012-4.
14. Laakso, S., M. Scheinin & M. Anttila: Determination of erythromycin base and 2′-acetylerythromycin in human plasma using high-performance liquid chromatography with electrochemical detection. J. Chromatogr. (Biomed. Appl.) 1990, 526, 475-486.
15. Lehtola, J., P. Jauhonen, A. Kesäniemi, R. Wikberg & A. Gordin: Effect of erythromycin on the oro-caecal transit time in man. Eur. J. Clin. Pharmacol. 1990, 39, 555-558.
16. Luurila, H., K. T. Olkkola & P. J. Neuvonen: Lack of interaction of eythromycin with temazepam. Ther. Drug Monit. 1994, 16, 548-551.
17. Luurila, H., K. T. Olkkola & P. J. Neuvonen: Interaction between erythromycin and nitrazepam in healthy volunteers. Pharmacology & Toxicology 1995, 76, 255-258.
18. Mandelli, M., G. Tognoni & S. Garattini: Clinical pharmacokinetics of diazepam. Clin. Pharmacokin. 1978, 3, 72-91.
19. Mattila, M. A. K. & H. M. Larni: Flunitrazepam: A review of its pharmacological properties and therapeutic use. Drugs 1980, 20, 353-374.
20. Olkkola, K. T., K. Aranko, H. Luurila, A. Hiller, L. Saarnivaara, J.-J. Himberg & P. J. Neuvonen: A potentially hazardous interaction between erythromycin and midazolam. Clin. Pharmacol. Therap. 1993, 53, 298-305.
21. Palva, E. S. &. M. Linnoila: Effect of active metabolites of chlordiazepoxide and diazepam alone, or in combination with alcohol, on psychomotor skills related to driving. Eur. J. Clin. Pharmacol. 1978, 13, 345-350.
22. Periti, P., T. Mazzei, E. Mini &. A. Novelli: Pharmacokinetic drug interactions of macrolides. Clin. Pharmacokin. 1992, 23 (2), 106-131.
23. Perucca, E., G. Gatti, G. Cipolla, E. Spina, S. Barel, S. Saback, M. Gips & M. Bialer: Inhibition of diazepam metabolism by fluvoxamine: A pharmacokinetic study in normal volunteers. Clin. Pharmacol. Therap. 1994, 56, 471-476.
24. Pessayre, D., D. Larrey, C. Funck-Brentano & J. P. Benhamou: Drug interactions and hepatitis produced by some macrolides, J. Antim. Chemother. 1985, 16, 181-194.
25. Phillips, J. P., E. J. Antal & R. B. Smith: A pharmacokinetic drug interaction between erythromycin and triazolam. J. Clin. Psychopharmacol. 1986, 6, 297-299.
26. Seppälä, T., M. Linnoila & M. J. Mattila: Drugs, alcohol and driving. Drugs 1979, 17, 389-408.
27. Smith, J. M. & H. Misiak: Critical flicker frequency (CFF) and psychotropic drugs in normal human subjects A review. Psychopharmacology 1976, 47, 175-182.
28. Stone, B. I.: Pencil and paper tests sensitivity to psychotropic drugs. Brit. J. Clin. Pharmacol. 1984, 18, 15S-20S.
29. The Supelco Reporter: Chromatography and chemical standard news: Simultaneously analyzed benzodiazepines by HPLC. International vol. IV, No. 5, November 1985.